With reference to e-mail received from BSE on 13th August, 2024 and the letter received from NSE, bearing reference no. NSE/CM/Surveillance/14603 dated 13th August, 2024, seeking clarification/ confirmation in respect of the news item appeared on the ‘Websitewww.economictimes.com’ captioned – ‘Torrent Pharma is said to seek raising $3 billion for KKR s stake in JB Chemicals’ on 13th August, 2024, Torrent Pharmaceuticals has clarified as follows: In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ‘Listing Regulations’), the Company has promptly intimated the stock exchanges regarding all events and disclosed all information, that have a bearing on the operations / performance of the Company which include all price sensitive information, etc., as and when required; At this stage, there is no material event/ information that requires disclosure under Regulation 30 of the Listing Regulations. If and when any proposal warranting a disclosure is considered by the board of directors of the Company, the Company shall promptly comply with the disclosure obligations under Regulation 30 of the Listing Regulations; Considering that the shares of the Company are freely traded on the stock exchanges, they noted that there has been no material price movement, and accordingly, the Company does not have any further comments.
The above information is a part of company’s filings submitted to BSE.